Filtered By:
Drug: Medroxyprogesterone
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 487 results found since Jan 2013.
Pulmonary embolism in menopausal hormone therapy: a population-based register study
CONCLUSION: PE was most common close to initiation of oral treatment. Transdermal MHT did not increase the risk of PE.PMID:36218141 | DOI:10.1080/13697137.2022.2127352
Source: Climacteric - October 11, 2022 Category: Geriatrics Authors: Micaela Sundell Anna-Clara Spetz Holm Mats Fredrikson Mats Hammar Mikael Hoffmann Jan Brynhildsen Source Type: research
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review
CONCLUSIONS: The conservative treatment may be an option for patients with stage IA G2 EEC who desire to preserve their fertility. The immunohistochemical markers evaluation looks promising in predicting response to conservative treatment. Further large series and randomized clinical trials are needed to confirm these results.PMID:36203482 | PMC:PMC9532104 | DOI:10.1155/2022/4070368
Source: Biomed Res - October 7, 2022 Category: Research Authors: Pierluigi Giampaolino Valeria Cafasso Dominga Boccia Mario Ascione Antonio Mercorio Francesco Viciglione Mario Palumbo Paolo Serafino Cira Buonfantino Maria Chiara De Angelis Paolo Verrazzo Giovanna Grasso Giuseppe Gullo Giuseppe Bifulco Luigi Della Corte Source Type: research
Evidence-Based Contraception: Common Questions and Answers
Am Fam Physician. 2022 Sep;106(3):251-259.ABSTRACTPrimary care clinicians are uniquely situated to reduce unintended pregnancy in the context of a patient's medical comorbidities, social circumstance, and gender identity. New evidence regarding contraception use has emerged in recent years. The copper intrauterine device is the most effective option for emergency contraception, with similar effectiveness found for the levonorgestrel-releasing intrauterine system, 52 mg, and both offer extended future contraception. Ulipristal given within 120 hours after unprotected intercourse is the most effective oral emergency contrace...
Source: American Family Physician - September 20, 2022 Category: Primary Care Authors: Scott L Paradise Corinne A Landis David A Klein Source Type: research
